For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220726:nRSZ8128Ta&default-theme=true
RNS Number : 8128T Calnex Solutions PLC 26 July 2022
26 July 2022
Calnex Solutions plc
("Calnex", the "Company" or the "Group)
Director / PDMR Dealing
Calnex Solutions plc (AIM: CLX), an established provided of test and
measurement solutions for the global telecommunications sector, confirms the
following transaction in the Company's ordinary shares.
The information in the below notification is disclosed in accordance with
Article 19 of the EU Market Abuse Regulation.
1 Details of PDMR/person closely associated with them ("PCA")
1.1 Name Ashleigh Greenan
1.2 Position/Status CFO / Director
1.3 Initial notification / amendment Initial
2 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
2.1 Description of the financial instrument Ordinary Shares of 0.125 pence each
2.2 Nature of the transaction Sale of Ordinary shares
2.3 Price(s) and volume(s) Price(s) Volume(s)
£1.58 22,926
2.4 Aggregated information
· Aggregated volume
· Price 22,926
· Total
£33,223.08
2.5 Date of the transaction 25 July 2022
2.6 Place of the transaction London Stock Exchange
2.4
Aggregated information
· Aggregated volume
· Price
· Total
22,926
£33,223.08
2.5
Date of the transaction
25 July 2022
2.6
Place of the transaction
London Stock Exchange
For more information, please contact:
Calnex Solutions plc Via Alma PR
Tommy Cook, Chief Executive Officer
Ashleigh Greenan, Chief Financial Officer
Cenkos Securities plc - Nomad +44 (0)131 220 6939
Derrick Lee / Peter Lynch
Alma PR + 44(0) 20 3405 0213
Caroline Forde, Harriet Jackson, Joe Pederzolli
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHPPUGWMUPPGCQ